Search

everythinglearnresearchcommunity

for

Search:↓

DHEA therapy improves pubic hair growth and psychological well-being in young females with central adrenal insufficiency.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Hormone replacement therapy improves skin health and reduces aging signs in postmenopausal women.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

TA-Ado effectively promotes hair growth and reduces hair loss.

Ayurveda-based care may improve quality of life for breast cancer patients without serious side effects.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

DHEA therapy improves pubic hair growth and psychological well-being in girls with central adrenal insufficiency.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Dutasteride microinfusion and microneedling both effectively treat male hair loss.

Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.

Eruca sativa oil, Aloe vera oil, and sodium carbonate may help improve cholesterol and tumor markers in breast cancer treatment.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Surgery improved symptoms and normalized hormone levels in a woman with an adrenal tumor.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Ayurveda-based care with Guduchi, Ashwagandha, and Curcumin improved quality of life for breast cancer patients without serious side effects.

The inhibitor affects androgen metabolism but not ovarian function.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.